Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease

被引:61
作者
Boutajangout, A [1 ]
Boom, A [1 ]
Leroy, K [1 ]
Brion, JP [1 ]
机构
[1] Free Univ Brussels, Sch Med, Lab Histol Neuropathol & Neuroanat, B-1070 Brussels, Belgium
来源
FEBS LETTERS | 2004年 / 576卷 / 1-2期
关键词
Alzheimer; tau mRNA; tau isoform; Neurofibrilla-gamma tangle; cortex; cerebellum; white matter;
D O I
10.1016/j.febslet.2004.09.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Alzheimer's disease (AD), selective expression of tau isoforms night underlie the susceptibility of different brain areas to develop neurofibrillary tangles and this pattern might change in the disease. In this study, we have analyzed in control subjects and in sporadic AD patients the pattern of expression of tau mRNA and tau proteins in areas unaffected (cerebellar cortex, white matter), moderately affected (occipital striate cortex, thalamus, caudate nucleus, and putamen) or strongly affected by neurofibrillary tangles (temporal and frontal associative cortex). After RT-PCR amplification, five products corresponding to the tau mRNAs containing exons 2 and 3, exon 2, without exons 2 or 3, with exon 10 and without exon 10 were identified. In control subjects, these five PCR products were present in all areas except in white matter, where transcripts with exons 2 or exons 2 and 3 were not identified. In AD patients, the same pattern of transcripts was observed in different areas, regardless of the presence of neurofibrillary lesions. After dephosphorylation of soluble tau proteins, the six tau isoforms were identified in the same areas by immunoblotting, including in the white matter, suggesting that most tau isoforms with exons 2 and 3 are transported along axons. The relative expression of 0N3R isoforms was higher in the temporal cortex than in the cerebellar cortex, both in control and AD subjects. The qualitative pattern of expression was identical in subjects with or without an APOE4 allele. Our results suggest that splicing regulation of the tau gene and the relative expression of tau isoforms are not significantly changed in sporadic cases of the disease, although differential expression of tau isoforms in temporal cortex might underlie this brain area susceptibility to netirofibrillary tangles formation. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B V. All rights reserved.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 37 条
[1]   Tau function and dysfunction in neurons - Its role in neurodegenerative disorders [J].
Avila, J ;
Lim, F ;
Moreno, F ;
Belmonte, C ;
Cuello, AC .
MOLECULAR NEUROBIOLOGY, 2002, 25 (03) :213-231
[2]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[3]   Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease [J].
Brion, JP ;
Tremp, G ;
Octave, JN .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :255-270
[4]   A68 PROTEINS IN ALZHEIMERS-DISEASE ARE COMPOSED OF SEVERAL TAU ISOFORMS IN A PHOSPHORYLATED STATE WHICH AFFECTS THEIR ELECTROPHORETIC MOBILITIES [J].
BRION, JP ;
HANGER, DP ;
COUCK, AM ;
ANDERTON, BH .
BIOCHEMICAL JOURNAL, 1991, 279 :831-836
[5]   TAU IN ALZHEIMER NEUROFIBRILLARY TANGLES - N-TERMINAL AND C-TERMINAL REGIONS ARE DIFFERENTIALLY ASSOCIATED WITH PAIRED HELICAL FILAMENTS AND THE LOCATION OF A PUTATIVE ABNORMAL PHOSPHORYLATION SITE [J].
BRION, JP ;
HANGER, DP ;
BRUCE, MT ;
COUCK, AM ;
FLAMENTDURAND, J ;
ANDERTON, BH .
BIOCHEMICAL JOURNAL, 1991, 273 :127-133
[6]   Tau protein isoforms, phosphorylation and role in neurodegenerative disorders [J].
Buée, L ;
Bussière, T ;
Buée-Scherrer, V ;
Delacourte, A ;
Hof, PR .
BRAIN RESEARCH REVIEWS, 2000, 33 (01) :95-130
[7]  
Chambers CB, 1999, ANN NEUROL, V46, P325, DOI 10.1002/1531-8249(199909)46:3<325::AID-ANA8>3.0.CO
[8]  
2-V
[9]   MICROTUBULE-ASSOCIATED PROTEINS AND INVITRO ASTROCYTE DIFFERENTIATION [J].
COUCHIE, D ;
FAGES, C ;
BRIDOUX, AM ;
ROLLAND, B ;
TARDY, M ;
NUNEZ, J .
JOURNAL OF CELL BIOLOGY, 1985, 101 (06) :2095-2103
[10]   The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease [J].
Delacourte, A ;
David, JP ;
Sergeant, N ;
Buée, L ;
Wattez, A ;
Vermersch, P ;
Ghozali, F ;
Fallet-Bianco, C ;
Pasquier, F ;
Lebert, F ;
Petit, H ;
Di Menza, C .
NEUROLOGY, 1999, 52 (06) :1158-1165